Human drugs: Correction,

Text

---

Federal Register: September 1, 1998 (Volume 63, Number 169)Rules and RegulationsPage 46389From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr01se98-3

[Page 46389]

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Part 358

Docket No. 81N-0201RIN 0910-AA01

Pediculicide Drug Products for Over-the-Counter Human Use; Final Monograph; Technical Amendment; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule; technical amendment; correction.

SUMMARY: The Food and Drug Administration (FDA) is correcting a final rule that appeared in the Federal Register of August 13, 1998 (63 FR 43302). The document amended the regulation that established conditions under which over-the-counter (OTC) pediculicide drug products (products used for the treatment of head, pubic (crab), and body lice) are generally recognized as safe and effective and not misbranded. The document published with an incorrect address. This document corrects that error.

EFFECTIVE DATE: September 1, 1998. FOR FURTHER INFORMATION CONTACT: Carolyn C. Harris, Office of Policy (HF-27), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-443-2994.

SUPPLEMENTARY INFORMATION: In FR Doc. 98-21794, appearing on page 43302, in the Federal Register of August 13, 1998, the following correction is made: On page 43303, in the first column, beginning in the first line, ``12420 Parklawn Dr., rm. 1-23, Rockville, MD 20857'' is corrected to read ``5630 Fishers Lane, rm. 1061, Rockville, MD 20852''.

Dated: August 26, 1998. William K. Hubbard, Associate Commissioner for Policy Coordination.

FR Doc. 98-23400Filed8-31-98; 8:45 amBILLING CODE 4160-01-F

---